UBS Group AG - JOURNEY MED CORP ownership

JOURNEY MED CORP's ticker is and the CUSIP is 48115J109. A total of 21 filers reported holding JOURNEY MED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of JOURNEY MED CORP
ValueSharesWeighting
Q3 2023$3,987
+33.7%
1,455
-22.4%
0.00%
Q2 2023$2,981
-54.8%
1,875
-55.3%
0.00%
Q1 2023$6,591
+64.8%
4,198
+190.7%
0.00%
Q3 2022$4,000
-60.0%
1,444
-46.3%
0.00%
Q2 2022$10,000
-33.3%
2,689
-15.3%
0.00%
Q1 2022$15,000
-11.8%
3,174
-2.3%
0.00%
Q4 2021$17,0003,2480.00%
Other shareholders
JOURNEY MED CORP shareholders Q3 2022
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 224,295$6150.61%
B. Riley Financial, Inc. 429,595$1,177,0900.40%
TANG CAPITAL MANAGEMENT LLC 576,100$1,578,5140.22%
AMERICAN FINANCIAL GROUP INC 180,000$4930.17%
Nantahala Capital Management 348,663$955,3370.08%
Allegiance Financial Group Advisory Services LLC 10,000$27,4000.02%
BRIGHTON JONES LLC 23,020$63,0750.00%
GEODE CAPITAL MANAGEMENT, LLC 69,509$190,5150.00%
STATE STREET CORP 11,853$32,4770.00%
MILLENNIUM MANAGEMENT LLC 14,462$39,6260.00%
View complete list of JOURNEY MED CORP shareholders